Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

According to UBS, the company’s next major driver is the SURPASS cardiovascular outcomes trial. The bank added that Eli Lilly ...

A court-appointed special master recommended a bid backed by Gold Reserve and Koch over a rival hedge-fund offer. Krispy Kreme's top finance executive, Jeremiah Ashukian, is leaving the doughnut maker ...

Neurizon enters global licensing agreement with ElancoNeurizon Therapeutics (ASX:NUZ) has signed an exclusive global ...

In the ongoing case of Lilly LaRoque, the woman accused of killing 17-year-old Delaney Doherty in a head-on crash nearly two ...

The Montana Attorney General’s Office is stepping in to assist the Gallatin County Attorney’s Office following 18th District ...

An SA family shares a close encounter with celebratory gunfire as the city launches a public safety campaign warning against ...

Shahs of Sunset alum Lilly Ghalichi is pulling the plug on her marriage to Dara Mir. This marks the fourth time the couple ...

Head coach Brian Schottenheimer has no problem depending on the Cowboys past and culture to help the team's current players ...

Boris Becker is expecting his fifth child. Now his ex-fiancée Alessandra "Sandy" Meyer-Wölden speaks about the news for the ...

The Syracuse-Wawasee Historical Museum’s first Centennial program this summer will feature the history of the Spink property ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.